| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $113.37 | $23.85 | 375.28% | 213.91x | 53.95x | 14.38x | 17.36x | 1.55x | $106.92M | 0.90% | $705.78M | 6.70 | $12.15B | 1,549.20 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $29.10 | $8.15 | 257.18% | 138.57x | 66.06x | 8.19x | 16.58x | 1.19x | $39.15M | 1.03% | $220.58M | 1.69 | $3.74B | 82.33 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $234.03 | $82.34 | 184.24% | 38.37x | 35.25x | 6.51x | 23.13x | 1.26x | $793.95M | 2.54% | $1.35B | 10.14 | $32.59B | 27.64 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.94 | $17.21 | 364.49% | 74.71x | 68.39x | 7.38x | 9.53x | 1.90x | $182.84M | 2.95% | $654.15M | 8.43 | $6.07B | 50.61 | ||
| RPRX | ROYALTY PHARMA PLC | $59.62 | $36.00 | 65.59% | 31.71x | 10.97x | 10.46x | 3.50x | 0.64x | $2.92B | 11.02% | $9.79B | 21.99 | $42.43B | 36.08 | ||
| VCEL | VERICEL CORP | $41.02 | $7.93 | 417.22% | 85.46x | 73.29x | 6.84x | 5.68x | 2.10x | $61.66M | 2.94% | $370.04M | 7.25 | $2.07B | 46.94 | ||
| KRYS | KRYSTAL BIOTECH INC | $330.00 | $82.70 | 299.02% | 39.90x | 42.92x | 22.12x | 7.19x | 2.16x | $257.78M | 2.65% | $1.36B | 46.03 | $9.35B | 40.07 | ||
| HALO | HALOZYME THERAPEUTICS INC | $121.51 | $71.04 | 71.05% | 34.13x | 13.42x | 8.56x | 96.08x | 0.65x | $806.22M | 5.66% | $143.54M | 1.22 | $15.77B | 21.96 | ||
| TGTX | TG THERAPEUTICS INC | $56.00 | $22.86 | 144.96% | 18.18x | 55.86x | 9.93x | 14.19x | 1.88x | $17.39M | 0.22% | $604.08M | 4.26 | $8.84B | 63.50 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.05 | $18.64 | 200.66% | 147.50x | 20.33x | 3.18x | 1.72x | 0.97x | $738.18M | 6.81% | $6.32B | 32.68 | $14.16B | 36.72 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.27 | $7.55 | 36.03% | 10.81x | 9.44x | 4.47x | 2.80x | 0.94x | $82.01M | 13.50% | $217.65M | 3.68 | $466.05M | 6.03 | ||
| EXEL | EXELIXIS INC | $62.83 | $30.37 | 106.89% | 19.10x | 18.87x | 6.47x | 8.44x | 1.21x | $1.17B | 7.44% | $1.84B | 7.35 | $15.45B | 14.21 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $214.42 | $179.78 | 19.27% | 14.05x | 8.97x | 2.95x | 2.90x | 0.57x | $1.62B | 11.95% | $4.80B | 75.98 | $16.69B | 10.33 | ||
| MDXG | MIMEDX GROUP INC | $4.68 | $1.20 | 291.12% | 117.00x | -25.97x | 1.95x | 3.16x | 1.35x | $44.50M | 6.43% | $216.00M | 1.46 | $563.53M | 24.71 | ||
| ADMA | ADMA BIOLOGICS INC | $10.73 | $6.92 | 55.01% | 14.90x | 13.49x | 4.78x | 5.89x | 0.87x | $116.47M | 4.75% | $408.21M | 1.79 | $2.47B | 10.58 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $298.50 | $85.66 | 248.47% | 29.64x | 31.61x | 20.61x | 6.15x | 2.22x | $130.62M | 2.18% | $967.52M | 48.22 | $6.08B | 21.78 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $508.75 | $147.09 | 245.87% | 29.36x | 26.63x | 10.25x | 6.37x | 2.21x | $3.80B | 2.94% | $20.25B | 79.81 | $124.78B | 22.67 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.27 | $30.60 | 25.06% | 12.19x | 9.18x | 2.31x | 2.23x | 0.69x | $354.90M | 16.01% | $999.24M | 17.25 | $1.83B | 6.55 | ||
| UTHR | UNITED THERAPEUTICS CORP | $541.51 | $186.99 | 189.59% | 17.91x | 20.03x | 7.31x | 3.63x | 3.29x | $1.09B | 4.74% | $6.40B | 150.24 | $21.42B | 12.78 | ||
| TECH | BIO-TECHNE CORP | $72.52 | $16.18 | 348.16% | 61.98x | 34.90x | 9.31x | 5.39x | 1.96x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.78 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $796.34 | $426.04 | 86.92% | 18.99x | 13.63x | 5.27x | 2.59x | 1.00x | $3.76B | 4.59% | $31.71B | 308.48 | $82.24B | 14.30 | ||
| VCYT | VERACYTE INC | $44.39 | $11.82 | 275.55% | 30.83x | 22.83x | 6.32x | 2.57x | 2.50x | $165.99M | 4.68% | $1.39B | 17.36 | $3.31B | 23.68 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.13 | $1.38 | -17.94% | 8.07x | -2.55x | 1.39x | 1.49x | 0.45x | $19.58M | 29.91% | $44.20M | 0.76 | $17.07M | 2.23 | ||
| INCY | INCYTE CORP | $113.27 | $57.16 | 98.16% | 13.95x | 33.69x | 3.90x | 3.62x | 1.67x | $1.92B | 8.46% | $6.34B | 31.66 | $19.01B | 9.19 |